The Power of the TRIAD Now Available with a Non-Invasive Collection
Duluth, Ga., March 31 /PRNewswire/ -- Are you a practitioner with limited access to blood draw facilities? Do you have patients that resist testing if a blood draw is required? Are you constantly looking for ways to make testing more convenient for your patients? If you answered yes to any of these questions, the TRIAD Bloodspot profile is perfect for your practice.
Metametrix Clinical Laboratory, a leader in nutritional and metabolic testing services, is pleased to introduce the new TRIAD Bloodspot Profile, a non-invasive specimen collection available for the powerful TRIAD test.
"Our main goal in creating the TRIAD Bloodspot option was to offer a convenient way for clinicians and patients to access this test," says Dr. J. Alexander Bralley, CEO of Metametrix Clinical Laboratory. "We are giving more clinicians access to the TRIAD, and offering ease of use for patients who can now complete the sample collection in the comfort of their own homes."
By integrating results from three different profiles, the TRIAD Bloodspot provides targeted, individualized interventions in one cost-effective package. The TRIAD Bloodspot compiles information from the following tests:
"The TRIAD Profile provides a broad approach for understanding a patient's conditions and needs," states Winston Cardwell, ND, LAc, SPHERIOS Medical Center. "The combination of markers for specific nutrient needs, essential amino acids, and IgG4 food analysis can reveal the core of most common clinical conditions - this profile is an indispensable tool."
For 25 years, Metametrix Clinical Laboratory has been an industry leader in producing innovative, Next Generation TechnologiesSM for measuring nutritional insufficiencies, metabolic dysfunction, as well as toxic influences on health. Metametrix is committed to applying the latest advances in testing services to functional and integrative medicine with a focus on quality, innovation, and education.
|SOURCE Metametrix Clinical Laboratory|
Copyright©2009 PR Newswire.
All rights reserved